查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1226701

維他命K2的全球市場:現狀分析與預測(2022年～2028年)

Vitamin K2 Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球維他命K2的市場規模，在預測期間內預計穩定成長約25％。維他命缺乏症的患者層的擴大，含維他命K2的產品的需求高漲，關節炎的病例增加等牽引市場成長。

本報告提供全球維他命K2市場相關調查分析，市場概要，各市場區隔、各地區的市場分析，市場成長的影響因素，市場趨勢，競爭情形，主要企業簡介等彙整資訊。

目錄

第1章 市場簡介

第2章 調查手法與前提

第3章 市場概要

第4章 摘要整理

第5章 COVID-19對維他命K2市場的影響

第6章 維他命K2市場收益(2020年～2028年)

第7章 市場洞察:各來源

  • 天然
  • 合成

第8章 市場洞察:各產品

  • MK-4
  • MK-7
  • 其他

第9章 市場洞察:各用途

  • 醫藥品
  • 營養補充品和食品
  • 其他

第10章 市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區

第11章 維他命K2市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第12章 維他命K2市場機會

第13章 維他命K2市場趨勢

第14章 需求與供給分析

  • 需求分析
  • 供給分析

第15章 價值鏈分析

第16章 競爭模式

  • 競爭情形
    • 波特的五力分析

第17章 公司概要

  • DSM
  • SEEBIO BIOTECH(SHANGHAI)CO., LTD.
  • Viridis BioPharma Pvt. Ltd.
  • Lesaffre
  • KYOWA HAKKO BIO CO,. LTD.
  • International Flavors & Fragrances Inc.
  • GeneFerm Biotechnology Co., Ltd.
  • DuPont
  • Kappa Bioscience
  • Vox Nutrition

第18章 免責聲明

簡介目錄
Product Code: UMME211588

The vitamin K2 Market is expected to grow at a steady rate of around 25% during the forecast period. Vitamin K2 is naturally produced in human intestines by bacteria. The western diet is deficient in vitamin K2; hence pharmaceuticals and supplemental diets are required to provide vitamin K2. The market is expanding as a result of an expanding patient base with vitamin deficiencies, rising demand for products containing Vitamin K2, and rising cases of arthritis. For instance, according to the Centers for Disease Control and Prevention (CDC), around 1 in 4 US adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis.

Along with calcium and vitamin D, vitamin K2 may be an effective supplement for the treatment of osteoporosis that is toxic-free and comparable to bisphosphonate therapy. By reducing arterial calcification, it may also considerably reduce cardiovascular morbidity and mortality. In the cases of diabetes, cancer, and osteoarthritis, vitamin K2 appears promising. Although a dosage adjustment is necessary, the use of vitamin K during warfarin medication is safe and may help with INR (International Normalized Ratio) control.

Based on source, the market is segmented into natural and synthetic. Among them, synthetic category to witness higher CAGR during the forecast period. The high rate of production, an increase in vitamin deficiency disorders, increasing health awareness, and substantial economic expansion for nutritional supplements are the major factors for the growth of the vitamin K2 market.

On the basis of product, the market is categorized into MK-4, MK-7, and others. Among these, the MK-7 to hold a significant share in the market in 2020. This is mainly due to the growing usage of dietary supplements rising cases of coronary artery diseases because MK-7 based vitamin's reduces the risk of coronary artery diseases, and vitamin K2 as MK-7, improves bone density by making blood vessels softer and bones harder.

Based on application, the vitamin K2 market has been classified into pharmaceuticals, nutraceuticals & food, and others. The pharmaceuticals category is to witness a significant growth rate during the forecast period. This is mainly due to the changing food habits, changing lifestyle, health awareness, and standard of living. Also, the applications of vitamin K2 is useful in pharmaceutical industry focusing on dental, CVDs, and bone related deficiencies which will drive the market growth during the forecast period.

For a better understanding of the market adoption of the vitamin K2 industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the prevalence of effective medical facilities in nations like the United States and Canada, the rising use of herbal medicines, increasing healthcare expenditures, and the government's emphasis on health and wellness. Moreover, the inclination toward living a healthy life is leading to the growing consumption of supplements including vitamin K2 and the expansion of the food and beverage and cosmetic industries are the driving factors for the expansion of the regional market.

Some of the major players operating in the market include: DSM, SEEBIO BIOTECH (SHANGHAI) CO., LTD., Viridis BioPharma Pvt. Ltd., Lesaffre, KYOWA HAKKO BIO CO. LTD., International Flavors & Fragrances Inc., GeneFerm Biotechnology Co. Ltd., DuPont, Kappa Bioscience, Vox Nutrition

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Vitamin K2 Market
  • 2.2. Research Methodology of the Vitamin K2 Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE VITAMIN K2 MARKET

6 VITAMIN K2 MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY SOURCE

  • 7.1. Natural
  • 7.2. Synthetic

8 MARKET INSIGHTS BY PRODUCT

  • 8.1. MK-4
  • 8.2. MK-7
  • 8.3. Others

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Pharmaceuticals
  • 9.2. Nutraceuticals & Food
  • 9.3. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 VITAMIN K2 MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 VITAMIN K2 MARKET OPPORTUNITIES

13 VITAMIN K2 MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. DSM
  • 17.2. SEEBIO BIOTECH (SHANGHAI) CO., LTD.
  • 17.3. Viridis BioPharma Pvt. Ltd.
  • 17.4. Lesaffre
  • 17.5. KYOWA HAKKO BIO CO., LTD.
  • 17.6. International Flavors & Fragrances Inc.
  • 17.7. GeneFerm Biotechnology Co., Ltd.
  • 17.8. DuPont
  • 17.9. Kappa Bioscience
  • 17.10. Vox Nutrition

18 DISCLAIMER